Substance Use in Pregnancy
On this page
Direct answer
Alcohol has no established safe threshold in pregnancy — abstinence is the only advice — because foetal alcohol spectrum disorder (growth restriction, characteristic facies, neurodevelopmental impairment) is the leading preventable intellectual disability of prenatal origin. Tobacco, consumed in India in both smoked and smokeless forms, causes low birth weight, prematurity, abruption and sudden infant death; cannabis and cocaine add growth and placental harms. Opioid-dependent pregnancy is managed with maintenance therapy (methadone or buprenorphine), never abrupt withdrawal, because detoxification relapse rates are high and oscillating blood levels harm the fetus more than a stable dose — and the newborn then watches for neonatal abstinence syndrome (NAS), scored with the modified Finnegan tool and treated with oral morphine when thresholds are crossed. Universal screening is questioning, not urine: validated tools such as the 4Ps, applied non-judgementally at booking, catch far more than toxicology, and the management stance throughout is support and treatment rather than punitive referral.
What you must remember
- Alcohol: foetal alcohol spectrum disorder spans the full phenotype to subtle neurobehavioural impairment; classic features are midfacial hypoplasia, smooth philtrum, thin upper lip, microcephaly, growth restriction and cardiac defects — no safe level exists.
- Tobacco in Indian forms: bidi and cigarette smoking plus smokeless tobacco (gutkha, khaini) all restrict fetal growth; nicotine replacement is safer than continued smoking but the goal is cessation with behavioural support.
- Opioids: maintenance with methadone or buprenorphine is standard; supervised withdrawal in pregnancy is discouraged outside specialist protocols; buprenorphine associates with somewhat milder neonatal abstinence in trials; split dosing helps late-pregnancy clearance.
- Neonatal abstinence syndrome: onset within 24-72 hours (longer with buprenorphine), scored with the modified Finnegan scale; non-pharmacological care first (rooming-in, breastfeeding if not using illicit drugs, swaddling); oral morphine first-line when scores cross threshold.
- Stimulants: cocaine and amphetamines drive abruption, preterm birth, growth restriction and hypertensive crises; management is supportive, with no drug treatment.
- Screening tools: 4Ps (Parents, Partner, Past, Present) at booking, with laboratory testing used selectively and consented; a positive screen triggers brief intervention and referral, never refusal of care.
- Obstetric coordination: high-risk antenatal care, anomaly and growth surveillance, planned delivery where neonatal support exists, honest anticipation of NAS with the mother.
- Indian legal and social frame: narcotic dependence care runs through de-addiction services under the NDPS Act's treatment provisions; alcohol and tobacco harm dwarf illicit drugs nationally, and punishment-oriented approaches damage disclosure and outcomes.
A coordinated pathway from booking to discharge
A 25-year-old books at 14 weeks on buprenorphine maintenance after heroin use, smoking 10 bidis a day. The care plan stacks: continuation of buprenorphine under the de-addiction service with obstetric co-management, tobacco cessation support, third-trimester growth scans for the combined risk, anaesthetic awareness of opioid tolerance (higher analgesic requirements in labour), and a neonatal team briefed before delivery. After a term vaginal birth, the baby rooms in with the mother; modified Finnegan scores run above threshold at 48 hours; oral morphine is started with a standard wean while non-pharmacological measures continue. Breastfeeding on stable buprenorphine is supported — it eases NAS. Discharge planning includes contraception, mental health review, and a child-safety conversation framed as support rather than surveillance. Contrast a fetus exposed only to alcohol: no withdrawal, no medication — the damage is structural and lifelong, which is why the alcohol question is asked of every woman at booking, and why "occasionally" earns a brief intervention, not a pass.
Where students slip
The predictable errors: recommending opioid detoxification in pregnancy (relapse and fetal distress make maintenance safer), assuming NAS requires immediate pharmacological treatment (scoring and non-drug care come first — many exposed newborns never need morphine), and missing the Indian smokeless-tobacco angle — answering "smoking" when the question says gutkha. Candidates also blur FAS facies with other syndromes, forget that abruption plus severe hypertension in a young woman should prompt a cocaine history, and propose punitive reporting — the correct stance is screening, brief intervention and referral to treatment, maintaining the therapeutic alliance.
Frequently asked questions
Is any alcohol consumption safe in pregnancy?
No safe threshold has been established; abstinence is advised throughout pregnancy and preconception, since foetal alcohol spectrum disorder is dose-related but occurs across drinking patterns.
How is opioid dependence managed in pregnancy?
With maintenance therapy — methadone or buprenorphine under specialist supervision — continued through delivery, with obstetric high-risk surveillance; abrupt withdrawal is avoided.
What is neonatal abstinence syndrome and how is it assessed?
A newborn withdrawal syndrome with tremors, high-pitched cry, poor feeding and sleeplessness, scored with the modified Finnegan scale to guide non-pharmacological care and, when thresholds are crossed, oral morphine.
Which screening tool is used for substance use in pregnancy?
Validated questionnaires such as the 4Ps at booking, applied universally and non-judgementally, with laboratory testing reserved for selected, consented situations.
What fetal risks accompany tobacco use in pregnancy?
Low birth weight, preterm birth, placental abruption, stillbirth and sudden infant death syndrome — risks shared by smoked and smokeless forms, including gutkha and khaini.